MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
Europe
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
BD_Becton, Dickinson and Company (NYSE:BDX)
Organization & Developments: Becton Dickinson (BD)
Parents
BD_Becton, Dickinson and Company (NYSE:BDX)
Children
2008: U.S. Genomics developed biodefense and diagnostic technologies, and raised $4.5 million in private equity funding from Becton, Dickinson & Co in 2008, part of a strategic partnership for pursuing diagnostics for infectious diseases
2014: BD to buy CareFusion in $12.2 billion deal
2014: Becton Dickinson enhances point-of-care testing business with $40M acquisition_medcitynews (2014)
2014: Cepheid (NASDAQ: CPHD) and Becton, Dickinson and Company (NYSE: BDX) are among the companies also developing point-of-care tests similar to Lucigen’s
2015: How Much More Can Becton Dickinson Muscle Up With CareFusion?
2016: Becton Dickinson (BD) is Doubling Down on Diabetes Care
2017: 66--Becton Dickinson Cytometry Reagents
2017: BD Establishes Product Security Partnership Program to Enhance Cybersecurity of Medical Technology
2017: NIH-Maintenance Support Services for Becton, Dickinson and Company Equipment
2017: VA_66--Procurement of Becton Dickinson (BD) FACSMelody flow cytometry cell sorter system for the VA Bronx Medical Center
2017: VA_J-- SERVICE CONTRACT LSRII Becton Dickinson Equipment
2020: 7 states ally to buy COVID-19 antigen tests, BD and Quidel to get initial orders
2020: BD launches coronavirus antigen test, 2nd to get FDA emergency use authorization
2020: Feds commit to buy Becton, Dickinson rapid COVID-19 test system
2021: BD inks BARDA contract to develop COVID tests for the long future of the pandemic
2021: Two separate product lines to detect SARS-CoV-2 in 15 minutes or less. One is a lateral flow immunoassay with a reader which delivers electronic results intended to be used in point-of-care settings. The second is an at-home lateral flow test that is digitally read by a smartphone.
2022: BD teams up with Labcorp to develop new companion diagnostic tests using flow cytometry
2022: BD’s PureWick female external catheter is a noninvasive urine output management system for female patients.
2024: BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
2024: Becton, Dickinson and Company 2024 Q1 - Results - Earnings Call Presentation
2024: Becton, Dickinson and Company Q4: Shifting To High-Growth Areas_ seekingalpha.com
2024: Becton, Dickinson And Company: Growth Starts To Normalize (Rating Upgrade)_
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.
BD Ventures
Becton Dickinson (BD): Products
Becton Dickinson (BD):Business Units
Becton Dickinson manufactures and sells medical supplies and devices and diagnostic systems for use by healthcare professionals, research institutions, industry and the general public
Developments: BD
Organization: BD
Jumps
*Key People: Becton Dickinson (BD)
Finance & Acquisitions: Becton Dickinson (BD)